Stories in Friday's Edition
Stories in Friday's edition
Filed under: Illinois Drug Abuse
Donald "Rick" Pruett, 52, is scheduled to have his criminal sexual abuse trial start on Sept. 9 in front of Judge William Mays. A pretrial hearing will be held on Aug. 30. A motion hearing will be held July 24. …. RICO-GANG ARRESTS: Several dozen …
Read more on Quincy Herald Whig
The new face of heroin
Filed under: Illinois Drug Abuse
Student Pleads Guilty in Fake ID Operation
Student pleads guilty in fake ID operation
Filed under: Illinois Drug Abuse
Arturo Perez-Vera, 19, of Grayslake, pleaded guilty Thursday before Champaign County Judge Tom Difanis to unlawful use of identification, a Class A misdemeanor, in connection with his arrest in January. UI police were sent to Perez-Vera's room in …
Read more on Champaign/Urbana News-Gazette
Trucker charged in March 2012 fatal wreck
Filed under: Illinois Drug Abuse
Elderly Runner Got Late Start
Elderly runner got late start
Filed under: Illinois Drug Rehabs
"They got all excited," said Campbell, "because they found when they had a world-record beater, there was a need for a drug test, and they didn't know what in the world to do about it." He waited for nearly an hour as officials huddled. … At first …
Read more on GoErie.com
Local man who struggled with addiction: God is recovery
Filed under: Illinois Drug Rehabs
Receptos to Deliver Scientific Presentations at Digestive Disease Week 2013 …
Receptos to Deliver Scientific Presentations at Digestive Disease Week 2013 …
Filed under: Illinois Drug Treatment Centers
This finding is reproducible in animal models of IBD and may further support the mechanism by which an S1P1R modulator would play a therapeutic role in the treatment of IBD. These data … The Company is also developing RPC4046, an anti-interleukin-13 …
Read more on GlobeNewswire (press release)
Onyx Pharmaceuticals Announces Data Presentations at 49th American Society …
Filed under: Illinois Drug Treatment Centers
New Clinical Trial Investigates APOKYN for Treating Debilitating Morning …
New clinical trial investigates APOKYN for treating debilitating morning …
Filed under: Drug Treatment Centers Illinois
AM IMPAKT, short for Apokyn for Motor IMProvement of Morning AKinesia Trial, is a Phase IV, multi-center, open-label study that will enroll approximately 100 subjects at 12 study sites across the US. “APOKYN, which has offered great benefit to …
Read more on EON: Enhanced Online News (press release)
MDS Symposium 2013 Update – Day Two, Morning Sessions
Filed under: Drug Treatment Centers Illinois
MEK Inhibitors as a Chemotherapeutic Intervention in Multiple Myeloma
MEK inhibitors as a chemotherapeutic intervention in multiple myeloma
Filed under: Illinois Drug Treatment Centers
The antitumour effect of BAY8697655 has been established in mouse xenograft models, with potent growth inhibition observed during drug treatment.57 Early data from the BAY8679655 phase I trial demonstrates good drug tolerability, with rash being the …
Read more on Nature.com
2-year-old girl receives windpipe made from stem cells, can breathe and eat …
Filed under: Illinois Drug Treatment Centers